← Back to headlines
Breakthrough reported in personalized cancer vaccines
Merck and Moderna announced that a personalized cancer vaccine showed promise in preventing the return and spread of melanoma in a large trial involving over 1,000 patients, offering new hope for cancer patients.
23 Aug, 13:28 — 23 Aug, 13:28
